Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
345.00    0.00 (0.00%)
Bid:
330.00
Ask:
360.00
Spread: 30.00 (9.091%)
Market Cap: £32.96m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

PDMR and PCA Shareholding

3 Feb 2025 07:00

RNS Number : 5467V
Cropper(James) PLC
03 February 2025
 

James Cropper plc

(the "Company")

 

PDMR and PCA Shareholding

 

The Company has been notified that, on 31 January 2025, Mark Cropper (Non-Executive Chair) transferred 5,000 ordinary shares of 25p each ("Shares") in the Company to his son, James Cropper, for a consideration of £1.975 per Share.

 

In addition, following a change in age, the Company has been notified that 26,349 Shares in the Company previously reported within Mark Cropper's beneficial ownership have now transferred to the beneficial ownership of his son, James Cropper.

 

Following the above changes, the beneficial interests of Mark Cropper and his son, James Cropper, in the Company's share capital are as follows:

 

Shareholding

Mark Cropper

James Cropper

No. Shares

% share capital*

No. Shares

% share capital*

Beneficial

1,895,977

19.8

31,349

0.33

Non-beneficial

559,571

5.9

0

0

Total

2,455,548

26.0

31,349

0.33

*based on the Company's current issued Share capital of 9,554,803 Shares

 

Mark Cropper and members of the Cropper, Willink and Acland families are deemed to act in concert and are regarded by the Takeover Panel as being members of a concert party as detailed in the Company's circular to shareholders dated 30 June 2015 (the "Concert Party"). The Concert Party has a collective interest in 3,624,109 Ordinary Shares representing 37.9% of the Company's issued share capital.

Enquiries

 

James Cropper plc

Matt Ratcliffe, General Counsel and Company Secretary

Tel: +44 (0) 1539 722 002

 

Shore Capital - (NOMAD and Broker)

Daniel Bush, David Coaten, Henry Willcocks, Lucy Bowden

Tel: +44 (0) 7601 6100

 

Buchanan Communications - Financial PR

Chris Lane, Charles Ryland, Jamie Hooper, Verity Parker

jamescropper@buchanancomms.co.uk

Tel: +44 (0) 207 466 5000

 

 

 

 

The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):

1.

Details of person discharging managerial responsibilities/person closely associated

 

a)

Name

(i) Mark Cropper

(ii) James Cropper

2.

 

Reason for the notification

a)

Position/status

(i) Mark Cropper: Non-Executive Chair

(ii) James Cropper: PCA of Mark Cropper

b)

Initial notification/amendment

Initial Notification

3.

Details of the issuer

 

a)

Name

James Cropper plc

 

b)

Legal Entity Identifier

213800XM78VTDYGBRM93

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

 

a)

Description of the

financial instrument

Ordinary Shares of 25 pence each

b)

Identification code of the Financial Instrument

GB0002346053

c)

Nature of the

transaction

(i) Sale of 5,000 Shares by Mark Cropper to James Cropper

(ii) Transfer of 26,349 Shares by Mark Cropper to James Cropper

d)

Currency

GBP

 

e)

Price(s) and volume(s)

 

Price(s)

Volume(s)

(i)

£1.975 per Share

5,000

(ii)

Nil

26,349

 

f)

Aggregated

information

- volume

- Price

- Total

 

 

 

(i) Volume: 5,000

(i) Price: £1.975

(i) Total: £9,875

 

(ii) Volume: 26,349

(ii) Price: Nil

(ii) Total: N/A

 

g)

Date of the transaction

31.01.2025

h)

Place of the transaction

Off market

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSDIFWFEISELF
Date   Source Headline
14th Apr 20267:00 amRNSFull Year Trading Update
27th Mar 20262:50 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RCollaboration with Hexcel on Composite Recycling
5th Dec 20259:34 amRNSHolding(s) in Company
2nd Dec 20257:00 amRNSPCA Shareholdings
17th Nov 20257:00 amRNSInterim Results
5th Nov 20257:00 amRNSNotice of Results and Investor Presentation
20th Oct 20257:00 amRNSCorrection: PDMR and PCA Shareholdings
17th Oct 20254:12 pmRNSPDMR and PCA Shareholdings
15th Sep 20257:00 amRNSDirector/PDMR Shareholding
3rd Sep 20253:34 pmRNSResult of AGM
3rd Sep 20257:00 amRNSAGM Trading Update
7th Aug 20257:00 amRNSNotice of Annual General Meeting
4th Aug 20257:00 amRNSGrant of Awards under Long-Term Incentive Plan
17th Jul 20257:00 amRNSFull Year Results
15th Jul 20257:00 amRNSNotice of Full Year Results
7th Jul 20257:00 amRNSTrading and Paper & Packaging Customer Update
23rd Jun 20257:00 amRNS-RRecording of Capital Markets Event Presentation
18th Jun 20257:00 amRNSStrategy Update and Capital Markets Event
9th Jun 20257:00 amRNSRevised Terms Agreed for UK Banking Facility
5th Jun 20257:00 amRNS-RNotice of Capital Markets Event
19th May 20257:00 amRNSDirector/PDMR Shareholding
12th May 20257:00 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSFull Year Trading Update
1st May 20259:14 amRNS€1.75m sale of non-core IP assets
1st Apr 20257:00 amRNS-RStrategic Collaboration with HOERBIGER
14th Feb 20253:32 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSPDMR and PCA Shareholding
30th Jan 20257:00 amRNSConfirmation of Chief Executive Officer Succession
7th Jan 20257:00 amRNSDirectorate Change
23rd Dec 20249:21 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSInterim Results
4th Nov 202412:03 pmRNSNotification of Major Holdings
1st Nov 20241:05 pmRNSNotice of Interim Results
29th Oct 20247:00 amRNSChief Executive Officer Succession
10th Oct 202410:14 amRNSDirector/PDMR Shareholding
8th Oct 20244:39 pmRNSDirector/PDMR Shareholding
10th Sep 20243:19 pmRNSGrant of Awards under Long-Term Incentive Plan
4th Sep 20244:32 pmRNSResult of Annual General Meeting
4th Sep 20247:00 amRNSAGM Trading Update
5th Aug 202411:56 amRNSNotice of Annual General Meeting
23rd Jul 20247:00 amRNSFull Year Results
22nd Jul 20249:43 amRNSDirectorate Changes
10th Jul 20247:00 amRNSNotice of Full Year Results
14th Jun 202411:00 amRNSAgreement of Bank Covenant Amendments
23rd May 20247:00 amRNSAppointment of MD, Advanced Materials
30th Apr 20247:00 amRNSFull Year Trading Update
12th Mar 20243:06 pmRNSDirector/PDMR Shareholding
8th Mar 20242:25 pmRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.